Non-Clinical
Health Innovation Labs
Sahlgrenska Science Park offers flexible labs and office services at the heart of Gothenburg’s life science ecosystem in the Sahlgrenska area.
CCRM Nordic
CCRM Nordic is a Non for profit company located in Gothenburg. CCRM Nordics core mission is to support the production of ATMP products from early stage to clinical trials, in order to get more products to patients. They also offer CMC support, analytic services, business strategy in the form of market and IP services, company creation and financing, and can support in grants application processes.
Stina Simonsson
Research focuses on stem cell biology, and regenerative medicine with the goal of generating functional tissues for repair or replacement of damaged organs. The work spans cellular reprogramming and Induced Pluripotent Stem cell biology to the development of 3D bioprinter tissues.
Marcus Wilhelmsson
Research focuses on the development of novel methods for visualising and tracking RNA and DNA in biological systems. By designing fluorescent nucleic acid building blocks that can be incorporated into natural or therapeutic RNA molecules, the work enables real-time studies of nucleic acid localisation, dynamics, and function in living cells. These technologies provide important analytical tools for the development and evaluation of RNA-based therapeutics and ATMPs, supporting studies of delivery, cellular uptake, stability, and biological activity.
Leonardo de Assis
Research combines molecular and cellular biology, advanced 2D and 3D tissue models, and multi-omics technologies to investigate cellular responses and tissue function in the skin. Experimental platforms include reconstructed human skin, ex vivo human tissue, and animal models, providing capabilities that are relevant for disease modelling, biomarker discovery, and preclinical assessment of regenerative medicine and ATMP-related strategies.
Kristina Vukusic
Expertise in cell therapy and ATMP development, including GMP production of autologous chondrocytes and as the quality person at the Cell and Tissue Lab. Research focuses on stem-cell-based regenerative medicine, particularly the differentiation of human induced pluripotent stem cells (iPSCs) into implantable chondroprogenitors. Performed large-animal studies evaluating stem-cell-based ATMP approaches for cartilage repair, alongside basic research into stem-cell niche biology in cartilage and the heart. Developed the advanced-level course BMA123, covering introduction to ATMP and relevant laboratory methods. She serves as project leader for Sahlgrenska Academy within SCALE.
Joakim Håkansson
Research focuses on regenerative medicine and the development of preclinical models for evaluating the safety and efficacy of advanced therapies. The work combines in vivo disease and regeneration models, 3D bioprinting, and biomechanical assessment to support the development and translation of ATMPs, pharmaceuticals, and medical devices.
Hanna Mårtensson
Research focuses on polymer-based gene delivery systems and on the development of improved preclinical models for evaluating nucleic acid therapeutics. The work combines biomaterials, cell biology, flow cytometry, and advanced microscopy to investigate the performance, cellular uptake, and biological effects of gene delivery platforms.
Fredrik Bergh Thorén
Focuses on cancer immunology, particularly on how natural killer (NK) cells recognize and eliminate cancer cells, and how these mechanisms can be harnessed to develop improved cancer immunotherapies.
Daniel Midtvedt
Research combines biophysics, advanced microscopy, and machine learning to develop quantitative methods for studying cells, biomolecules, nanoparticles, and complex biological systems. Work includes label-free optical characterization, holographic microscopy, AI-enabled image analysis, and the investigation of biological interactions at the nano- and microscale. These technologies support a wide range of applications relevant to ATMPs, including cell characterization, biomaterial development, and quality control of biological products.
Camilla Hesse
Educational activities focus on biomedical laboratory science, with a particular emphasis on practical training in Advanced Therapy Medicinal Products (ATMPs). Through laboratory-based teaching, course development, and training of future biomedical laboratory scientists, this work contributes to building the competence and infrastructure required for the development and implementation of advanced therapies. Research interests in transfusion medicine, blood products, and laboratory methods further support the translational ecosystem surrounding ATMP research and healthcare applications.
Caroline Beck Adieles
Research focuses on developing optics-, photonics-, and microfluidics-based technologies for life science applications. Work spans single-cell analysis, cell-cell communication, organ-on-chip systems, tissue formation, and drug screening, often integrating advanced image analysis and AI-based methods to study complex biological systems. These approaches provide important enabling technologies for regenerative medicine, cell engineering, and future ATMP development.
Anders Lundgren
Research focuses on developing advanced surface chemistries on biomaterials and nanoparticles that provide defined cellular cues for controlling and studying cell behaviors. The work combines surface engineering, microfluidics, high-resolution microscopy, and quantitative image analysis to investigate how cells interact with engineered materials and biological interfaces, with particular emphasis on adhesion, signalling, mechanobiology, and transport phenomena. Serves as project leader for the Faculty of Science and Technology at University of Gothenburg within the SCALE project.
Alexandra Stubelius
Research at the interface of nanomedicine, immunology, and bioengineering focuses on developing nanoparticle-based strategies for RNA delivery and for studying inflammatory and immune processes in complex biological tissues. The work combines advanced biomaterials, microphysiological systems such as vessel-on-chip and blood-on-chip models, and mRNA technologies to investigate mechanisms of transport and therapeutic delivery relevant to next-generation biologics and ATMPs.
From classroom to cleanroom: building a skilled cell and gene therapy workforce
The demand for the CGT workforce exceeds the capacity of current training programs to produce professionals ready for Good Manufacturing Practice (GMP) operations and associated quality and regulatory requirements.
Tissue engineering
(KPO065) Although the lives of thousands of people are saved by reconstructive surgeons, many people are still waiting for organ donations. Reconstructive surgery became, in the last decade, a new discipline - tissue engineering with focus on the fabrication of living replacement parts for the body in the laboratory. Tissue engineering includes biology, chemistry, material science, engineering, immunology and transplantation. This course provides a general understanding of tissue growth and development and the tools and theoretical information needed to design tissues and organs.
Elicera Therapeutics
Elicera Therapeutics AB is a clinical stage immuno-oncology company developing next generation, iTANK-armed, cell and gene therapies based on CAR T-cells and oncolytic viruses.
Stem Cells and Applied Regenerative Medicine
(8MEA11) Stem cell research and regenerative medicine are new interdisciplinary fields in biomedical sciences that aim to replace defective parts or cells in the human body. The aim of this course is to introduce students into selected topics of regenerative medicine, and to provide deeper knowledge about stem cells.
Design of Biotechnical Processes
(TFTB52) The student will obtain engineering skills to analyze and perform design of industrial biotech tools, process and production systems, as well as assess and evaluate production and process economy conditions.
Production of Biopharmaceuticals
(TFTB53) In the course, the students will learn what the different classes of biological drugs (biopharmaceuticals) are, what distinguishes biological drugs from other types of drugs, and how different classes of biopharmaceuticals are produced.
Stem Cell Engineering
(TVCB13) Growth and differentiation factors. Processes of cell differentiation, apoptosis, regulation and control of the function of stem cells. Epigenetic regulation of gene expression and its role in cell growth and cell function. Principles of aberrant growth control, cancer, stem cell niches, cell editing technologies as well as advantages and disadvantages of these technologies. Reproductive and therapeutic cloning, regenerative medicine and induced pluripotent stem cell technology. Ethical aspects on stem cell technology.
Animal Cell Culture Technology for the Production of Biologics
(CB203V) Protein drugs or biopharmaceuticals are taking an increasing part among therapeutic drugs world-wide. Furthermore, a large majority of these are produced from animal cell cultivation based processes. This course gives the fundaments of animal cell cultivation for the production of protein drugs in the pharmaceutical industry, and how these processes are developed, for which practical application is given through simulation software.
Stem Cell Biology and Regenerative Medicine
(BIMM25) This is an elective course in the Master's programme in Biomedicine. Step into the world of stem cells and regenerative medicine. This course introduces you to cutting-edge research and the science behind cell reprogramming, regeneration, and ethical challenges shaping tomorrow’s therapies.
Handling, maintenance and understanding of human pluripotent stem cells
Are you new to working with human pluripotent stem cells? We will teach you how! We offer a new course containing substantial hand-on practice in the cell lab as well as seminars covering topics such as history, growth, quality controls and how they can be used in research and the clinic.
Stem Cells and Organoids Models with Focus on Regenerative Medicine
(H5F5562) The purpose of the course is to enable doctoral students to obtain a basic understanding of stem cell biology with focus on production and study of organoids in vitro culture, cell-based therapies, genome engineering and translational medicine. Experts in the field will provide a fresh overview of clinical and pre-clinical research aiming at development of novel treatment possibilities, but also discussing current limitations and general ethical aspects.